Inconsistencies in the association between the JAK2V617F mutation and PRV-1 over-expression among the chronic myeloproliferative diseases
Open Access
- 26 January 2006
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 132 (5), 652-654
- https://doi.org/10.1111/j.1365-2141.2005.05951.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2Blood, 2005
- Pathogenesis of Thrombosis in Essential Thrombocythemia and Polycythemia Vera: The Role of NeutrophilsSeminars in Hematology, 2005
- The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patientsBlood, 2005
- Concomitant neutrophil JAK2V617F mutation screening and PRV‐1 expression analysis in myeloproliferative disorders and secondary polycythaemiaBritish Journal of Haematology, 2005
- Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disordersBlood, 2005
- Clinical implications of the JAK2 V617F mutation in essential thrombocythemiaLeukemia, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005
- PRV-1 , erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemiaBritish Journal of Haematology, 2004